“A friend is a gift you give yourself.”
– Robert Louis Stevenson
Cheap Enough
In hushed tones, senior executives of some of the largest pharmaceutical companies say that they want to work with the regulator and abide by the law but Dilip G Shah has taken the conflict very personally
The public posturing of the IPA, which is in sharp contrast to its own report, shows the extent of the misinformation being floated
The industry agrees that in the last three years, price regulation has affected them only marginally, not nearly enough to reverse the growth
To look into the matter, the DoP has set up a committee, whose objective is to ensure enhanced access to drugs and a streamlined price control mechanism
On 13 April, a day before the Easter weekend, many drug manufacturers went on their breaks feeling a little agitated but mostly helpless. It was the day, the spokesperson of the Indian Pharmaceutical Alliance (IPA), representing its (invite only) members—over 20 large companies including Sun Pharma, Dr Reddy’s, Lupin and Cipla—went public with his anger.
Dilip G Shah referred to the pricing policy roll-out as “arbitrary”, and compliance to guidelines “difficult”.
Sign up to our India edition to read this story instantly
To sign up, you’ll create an account that will give you access to a new free story published once a week and archive of 214+ previously published free stories from our India edition. You’ll also receive one email every morning from us introducing the day’s story.
If you’ve already signed up, just enter your email below or login using Facebook or Google.
One free story every week. Access to 214+ older free stories from India edition
One email every morning from us, and The Nutgraf - our cracking Saturday newsletter
200 word summaries for all paid, subscriber-only stories
The Ken has invited you to sign up for The Nutgraf by The Ken.
The Ken has invited you to sign up for The Nutgraf by The Ken.
Having your name allows us to address you personally in emails and on our website. That’s all, nothing else.
The Ken has added you as a partner. Read The Ken as a couple. Sign in to get started.
The Ken has added you as a partner. Read The Ken as a couple. Sign up to get started.
Having your name allows us to address you personally in emails and on our website. That’s all, nothing else.
